ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

SNDX Syndax Pharmaceuticals Inc

21.70
-0.27 (-1.23%)
取引時間後
最終更新日: 07:00:02
15分遅延
名称 銘柄コード 市場 種別
Syndax Pharmaceuticals Inc SNDX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.27 -1.23% 21.70 07:00:02
始値 安値 高値 終値 前日終値
22.11 21.50 22.33 21.86 21.97
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0120:00PRNUSSyndax to Announce First Quarter 2024 Financial Results and..
2024/4/1105:05PRNUSSyndax Announces Participation at the Stifel 2024 Virtual..
2024/4/0820:00PRNUSSyndax Presents Positive Pediatric Data from Pivotal..
2024/4/0605:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
2024/3/2820:00PRNUSSyndax Announces Completion of Enrollment in AUGMENT-101..
2024/3/2705:05PRNUSSyndax Announces FDA Priority Review of NDA for Revumenib..
2024/3/1820:00PRNUSSyndax Announces Appointment of Steven Closter as Chief..
2024/3/0206:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
2024/2/2807:28EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2024/2/2807:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2806:05PRNUSSyndax Pharmaceuticals Reports Fourth Quarter and Full Year..
2024/2/2806:03EDGAR2Form 8-K - Current report
2024/2/2621:00PRNUSSyndax Announces Participation at Two Upcoming Investor..
2024/2/2106:05PRNUSSyndax to Announce Fourth Quarter and Year-end 2023..
2024/2/1502:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1421:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1411:44EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1006:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
2024/2/0206:10PRNUSSyndax Announces Participation at Two Upcoming Investor..
2024/1/0606:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
2024/1/0306:05PRNUSSyndax Announces Presentation at 42nd Annual J.P. Morgan..
2024/1/0221:00PRNUSSyndax Highlights Recent Updates and Anticipated 2024..
2023/12/2022:40EDGAR2Form 8-K - Current report
2023/12/2006:16PRNUSSyndax Announces Closing of Public Offering of Common Stock..
2023/12/1607:29EDGAR2Form 8-K - Current report
2023/12/1607:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/1513:07PRNUSSyndax Announces Pricing of $200 Million Public Offering of..
2023/12/1506:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/1506:00PRNUSSyndax Announces Proposed $150 Million Public Offering of..
2023/12/1306:05EDGAR2Form 8-K - Current report
2023/12/1302:00PRNUSSyndax Presents Positive Data from Pivotal AUGMENT-101 Trial..
2023/12/1121:30PRNUSSyndax Announces Positive Data for Revumenib in Patients..
2023/12/1120:33BWIncyte und Syndax präsentieren bei ASH-Plenarsitzung weitere..
2023/12/1107:00BWIncyte and Syndax Present Additional Data from Positive..
2023/12/0421:00PRNUSSyndax to Host Investor Event to Discuss Axatilimab and..
2023/12/0206:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
2023/11/2123:00PRNUSSyndax Announces Data from Pivotal AUGMENT-101 Trial of..
2023/11/0721:00PRNUSSyndax Announces Participation at Stifel Healthcare..
2023/11/0405:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
2023/11/0305:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0305:05PRNUSSyndax Pharmaceuticals Reports Third Quarter 2023 Financial..
2023/11/0305:03EDGAR2Form 8-K - Current report
2023/11/0222:00PRNUSSyndax Announces Results from the Pivotal AGAVE-201 Trial of..

最近閲覧した銘柄

Delayed Upgrade Clock